Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
Krause M, Henningsen A, Torge A, Juhl D, Junker R, Kenet G, Kowalski D, Limperger V, Mesters R, Anonymous, Rocke A, Shneyder M, Clausnizer H, Schiesewitz H, Nowak-Göttl U.
Krause M, et al.
Thromb Res. 2016 Dec;148:145-151. doi: 10.1016/j.thromres.2016.09.007. Epub 2016 Sep 13.
Thromb Res. 2016.
PMID: 27687905
No abstract available.